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Abstract
Different image techniques have been used to analyze mucociliary clearance (MCC) in
humans, but current small animal MCC analysis using in vivo imaging has not been well
defined. Bitter taste receptor (T2R) agonists increase ciliary beat frequency (CBF) and
cause bronchodilation but their effects in vivo are not well understood. This work analyzes
in vivo nasal and bronchial MCC in guinea pig animals using three dimension (3D) micro-
CT-SPECT images and evaluates the effect of T2R agonists. Intranasal macroaggreggates
of albumin-Technetium 99 metastable (MAA-Tc99m) and lung nebulized Tc99m albumin
nanocolloids were used to analyze the effect of T2R agonists on nasal and bronchial MCC
respectively, using 3D micro-CT-SPECT in guinea pig. MAA-Tc99m showed a nasal muco-
ciliary transport rate of 0.36 mm/min that was increased in presence of T2R agonist to 0.66
mm/min. Tc99m albumin nanocolloids were homogeneously distributed in the lung of
guinea pig and cleared with time-dependence through the bronchi and trachea of guinea
pig. T2R agonist increased bronchial MCC of Tc99m albumin nanocolloids. T2R agonists
increased CBF in human nasal ciliated cells in vitro and induced bronchodilation in human
bronchi ex vivo. In summary, T2R agonists increase MCC in vivo as assessed by 3D micro-
CT-SPECT analysis.
Introduction
The airways are constantly challenged by inhaledmicrobial pathogens. Mucociliary clearance
(MCC) is the primary physical defense against inhaled pathogens, toxins and particulates in
the respiratory system. Appropriate mucus production and coordinated ciliary activity are the
premises for effective clearance.
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There are many reasons why MCC could be impaired. The movements of the cilia can be
hindered directly as occurs in cilia genetic disorders (primary ciliary dyskinesia) or by tempo-
rary dysfunction caused by airway infection or environmental influences [1–3]. The mucus
layer can constitute the main problem when dehydration of the mucus leads to increased vis-
cosity whereby the ciliary clearance becomes ineffective [4, 5]. In chronic airway diseases,
hypersecretion of mucin leads to excessive amounts of mucus with an increased viscosity that
is hard to clear from the airways and in severe cases can end up forming mucus plugs whereby
infection or localized atelectasis can be observed [5, 6].
Eventually, the inflammation generated by defects in MCC can lead to bronchiectasis char-
acterized by permanent dilation of the airway and thickening of the bronchial wall [7]. All
severe chronic diseases involving defectiveMCC result in substantial morbidity in terms of
dyspnoea, recurring sinopulmonary infections, and frequent and productive coughs. The close
relationship with infection is also evident in patients with acute infectious exacerbation of
chronic obstructive pulmonary disease where large amounts of viscous sputum are produced
[5]. In this regard, many new therapies directed to improve MCC are currently under research,
including those directed to increase ciliary beat frequency (CBF), to reduce mucus secretion or
mucus viscosity, with the final objective to improve morbidity and clinical symptoms of upper
and lower chronic lung diseases [8].
Several technologies have been developed to monitor MCC. Thus for example, inhaled
radioaerosols containing insoluble technetium 99 metastable (Tc99m) labelled colloids have
been employed to monitor MCC by scintigraphy. This technique has been used for many years
to evaluate human pulmonary clearance studies, reflecting the combination of MCC, cough
clearance or the combination of both [9], thus assessing a possible link betweenmucociliary
dysfunction and pathophysiology of lung diseases or pharmacological challenges to the muco-
ciliary apparatus. However, different variations of radiocolloids (albumin/sulphur particles),
particle size selection, inhalation technique, gamma camera acquisition (static/dynamic/ sin-
gle-photon emission computerized tomography (SPECT)), particle deposition (nasal deposi-
tion, low airways deposition), reflects the difficultiesof technique application and that the
choice of ‘best’ method depends upon the specific aim of the test. Furthermore, small animal
MCC analysis using radiocolloid imaging has not been well explored which may limit MCC
preclinical research.
The present work analyzes different radiocolloid animal three dimension (3D) micro-com-
puter tomography (CT)-SPECT techniques, to study nasal and bronchial MCC as a potential
tool to evaluate MCC abnormalities as well as new pharmacological therapies directed to
improve MCC in chronic airway disorders. To this end we characterized different bitter taste-
sensing receptor (T2Rs) agonists on MCC in in vivo animal micro-CT-SPECT radionuclear
models. T2Rs activation increase CBF [10] and bronchodilation [11] providing an optimal con-
trol to characterize in vivoMCC techniques. The effect T2Rs agonists on in vitro CBF using
high speed video-microscopy and ex vivo bronchial relaxation in organ baths were also ana-
lyzed to corroborate in vivo analysis. Results obtained in this study provides different pre-clini-
cal models to characterizesMCC which may be of potential value to the study of different
upper and lower respiratory diseases as well as to evaluate new therapies directed to improve
MCC.
Methods
Animal experiments
Experimentation and handling were performance in accordance with the guidelines of the
Committee of Animal Ethics andWell-being of the University of Valencia (Valencia, Spain).
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Animal studies used pathogen-freemale Guinea pig (Harlan Iberica1, Barcelona, Spain) at 12
weeks of age. Guinea pig were housed with free access to water and food under standard condi-
tions: relative humidity 55 ± 10%; temperature 22 ± 3°C; 15 air cycles/ per hour; 12/12 h Light/
Dark cycle.
Nasal mucociliarytransport rate (NMTR)measurement in guinea pig. Guinea pig ani-
mals (~350 g) were anesthesized with intraperitoneal mixture of ketamin (70 mg/Kg) and
medetomidin (0.25 mg/kg). After a period of 10 min, the animals were placed into double-
chamber plethysmograph (DCP) with conical restrainer nouse-only system adapted to guinea
pig animals (250-400g animal; emka technologies, Paris, France). DCPwas connected to a ven-
tilation pump (model 683; Harvard Apparatus) to renewal of air inside the head chamber. A
vacuum pump N0022AN.9E (KNF Neuberger, Freiburg, Germany) was connected to the
chamber to drawn out the air introduced by ventilator. Air from ventilator and vacuum pump
were filtered through a 0.1μm PESU membrane filter (Sartorius stedium biotech, goettingen,
Germany). The head unit of the DCPwas connected to the nebulizer head unit (Aeroneb1 Lab
Nebulizer, Aerogen Inc. Galway, Ireland) provided with a filler cap. Nebulizer head unit was
controlled with a nebulization-controller device (emka technologies, Paris, France). A final vol-
ume of 300μl with vehicle (phosphate buffer), T2Rs agonist chloroquine, denatonium or sac-
charine at 1 mMwere deposited in the nebulizer head unit and nebulized to the nouse-only
system of the chamber head unit during 15 min. The flow rate of nebulization was controlled
with the nebulization-controller device to provide a 15 min cycle of nebulization. The nebuliza-
tion head emits a fine-droplet (mass median aerodynamic diameter< 3μm to 0.55 mm) aero-
sol at low velocity without heat and propellants and without pressure or volume fluctuations.
No residual liquid remained in the head unit indicating a high efficiency. Considering that the
trachea of guinea pigs with mean body weight of 400 g is a 3.51 ± 0.88 cm long and 0.21 ± 0.05
cm in diameter (mean ± SEM) and that the bronchioles, alveolar ducts, and alveolar sacs are
about the same diameter (0.01 to 0.015 cm), and the alveoli are approximately 0.008 cm in
diameter [12]) we can assume that nebulized solution reached the whole lung volume of guinea
pig. So deposition site of the drugs was nose, tracheal, bronchial and alveolar units. In this set-
ting, diameter of<3μm to 0.55 combine impaction and diffusion processes [13]. Drug solu-
tions were dissolved in phosphate buffer solution adjusted to pH 7.4 since pH can affect cilia
motility (acid pH decrease CBF) and bronchial contractility (acid pH increase bronchial
contractility).
After vehicle/drug delivery, a suspension of albumin macroaggregated Tc99m
(MAA-Tc99m) (Molipharma, Valencia Spain; 10 mCi; particle diameter 5–90μm) was intrana-
sally instilled (one droplet of 25 μL) on the nasal meatus using a micropipette. The animals
were introduced into the micro-CT-SPECT (Albira, Oncovision™, Valencia, Spain) in supine
position in a cradle made of plexiglas, and dynamic capture of micro computer tomography
(CT) and micro-SPECT images were acquired each 12 min during 60 min. The time of each
capture was 1min (until 300000 counts). Head and neck images were taken as follow: planar
scintigraphy in anterior (A), posterior (P) left and right lateral (LL and RL), and left and right
posterior oblique (LPO and RPO) views. The images were reconstructedwith filtered back pro-
jection algorithm using the Albira Suite 5.0 software (OncoVision, Valencia, Spain). The com-
bination of acquisition and reconstruction result in a final whole image matrix of 255255255
mmwith a pixel size of 0.250.250.25 mm. 252 image sections corresponding to the whole
head and neck images (3D images) were acquired in each capture and analyzed with the
PMOD™ software selecting a whole 3D volume of interest (VOI) after radioisotope administra-
tion (basal image). Nasal mucociliary transport rate (NMTR) was calculatedmeasuring the dis-
tance (milimeters) reached by the front of MAA-Tc99m radioparticles signal in 1 min (mm/
min). The experimental groups were control group (vehicle nebulization; n = 9) and test
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compound groups (chloroquine 1mM; n = 9; denatonium 1mM; n = 9, Saccharin 1mM; n = 9).
Drug concentrations were selected from previous studies as effective concentrations [11].
Bronchial mucociliaryclearance analysis using ventilated Tc99m DTPA, intratrtacheal
Tc99m albuminmacroaggregates or ventilated Tc99m albumin nanocolloids in guinea
pig. Guinea pig animals (~350 g) were anesthesized with intraperitoneal mixture of ketamin
(70 mg/Kg) and medetomidin (0.25 mg/kg). After a period of 10 min, the animals were placed
into double-chamber plethysmograph and drugs were nebulized as described in the NMTR
section. After drug delivery, three different techniques were assayed to evaluate bronchial
mucociliary clearance. 1) The animals were nebulized as described for the dugs with a solution
containing 300μl diethylene-triamine-pentaacetate 10 mCi (DTPA-Tc99m) (Molipharma,
Valencia, Spain) for 15 min. After DTPA-Tc99m delivery, the animals were removed from the
nebulizer chamber and allowed to breathe freely. 2) MAA-Tc99m (100 μL; 10 mCi; particle
diameter 5–90μm) particle suspension was intra-tracheally administered via the endotracheal
route as previously outlined [14, 15]. 3) A suspension of Tc99m albumin nanocolloids (Moli-
pharma, Valencia Spain; 10 mCi; particle diameter80nm) was nebulized during 15 min as
described for drugs.
For each of the three different radionuclear preparations SPECT dynamic scans were
acquired each 4 min during the first 60 min, and punctual acquisitions at 2h, 4h and 6h time
points on an ALBIRAmicro-SPECT system (Oncovision1, Valencia, Sapin) using pinhole col-
limators and a radius of rotation of 3.5 cm. Micro-CT images were acquired to locate radioiso-
tope signal in animal lungs. The time of each capture was 1min (until 300000 counts). Lung
images were taken as follow: planar scintigraphy in anterior (A), posterior (P) left and right lat-
eral (LL and RL), and left and right posterior oblique (LPO and RPO) views. The images were
reconstructedwith filtered back projection algorithm using the Albira Suite 5.0 software
(OncoVision, Valencia, Spain). The combination of adcquisition and reconstruction result in a
final whole image matrix of 255255255 mmwith a pixel size of 0.250.250.25 mm. 252
image sections corresponding to the whole lung (3D images) were acquired in each capture
and analyzed with the PMOD™ software selecting a whole 3D VOI after radioisotope adminis-
tration (basal image). During dynamic capture the animals were anesthetized. All scans were
performedwith gamma cameras with large field-of-viewdetectors, equipped with low energy
general purpose collimators. The analysis of MCC was performedwith the PMOD™ software
selecting a whole 3D VOI after radioisotope administration (basal image corresponding to the
100% of radiotracer lung deposition) and repeating measures at different times applying the
same VOI. Quantification was performed by analyzing the number of counts in the same VOI
applied to every image (counts per pixel unit) corrected for the radioactive decay of Tc99m.
Computerized tomography (CT) images were captured to visualize the anatomic location of
the SEPCT images. The experimental groups are defined as control group (phosphate buffer
vehicle ventilation; n = 12) and test compound group (Chloroqine 1mM; n = 12; Denatonium
1mM; n = 12, Saccharin 1mM; n = 12). Bronchial MCC was calculated in each individual as the
% of the lost of radiation counts on the whole VOI at each time point during the 6h period
being 100% of signal the SPECT acquisition at time 0 min.
Human experiments
Samples of nasal epithelial cells were obtained from adult healthy subjects, free of airway infec-
tions, by curettage of middle turbinate mucosa without the use of local anaesthesia to avoid
any external influence as previously outlined [16]. Lung tissue was obtained from patients who
were undergoing surgery for lung carcinoma. Bronchial isolation was obtained in healthy tissue
as far from the tumor lesion as previously outlined [17]. The protocol was approved by the
Micro-CT-SPECT Mucociliary Function Analysis of Bitter Taste Agonists In Vivo
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local research and independent ethics committee of the University General ConsortiumHospi-
tal of Valencia (CEIC25/2015). Informed written consent was obtained from each participant.
Measurement of ciliarybeat frequency in human nasal epithelial cells. Nasal epithelial
cells frommiddle turbinate mucosa were introduced into 1 ml of Dulbecco’s modifiedEagle’s
medium (DMEM, Cambrex) supplemented with 10% foetal bovine serum, 2 mM glutamine,
penicillin (100 U/ml) and streptomycin (100 mg/ml). The nasal biopsy was partially disaggre-
gated and dissolved in this medium. Culture dishes treated with 0.5% gelatine (Corning Incor-
porated Costar 3513, 12-wells) to facilitate adherence of ciliated cells were used to grow 150 μl
samples of nasal epithelium biopsyas previously outlined [16]. The study was conducted
between 23°C and 27°C room temperature. Measurement of CBF and functional ciliated cell
analysis followed previously describedprotocols [16]. Briefly, cells were imaged with a digital
high speed video (DHSV) imaging technique using a Nikon Eclipse TS100 microscope
equipped with a 40x Nikon phase-contrast objective. Contrast enhanced video images were
selected and the light intensity of the selected pixels was recorded on a frame-by-frame basis.
In addition, the magnitude spectrum from a fast Fourier transformation of the variation of
pixel intensity signal was analysed in an average of six different regions of (3 x 3 pixels) the
cilia in individual cells in a minimum of 10 cells per experiment. CBF experiments were per-
formed with cells submerged in Hanks' Balanced Salt Soln (HBSS) (Lonza, Cambridge, UK) at
an apical volume of 100 mL. After equilibration, basal CBF was determined by 10 successive
measurements obtained from the same ciliated site. Growing concentrations of T2R agonists
were added every 10 minutes to generate cumulative concentration response curves between
10−8 M to 10−3 M concentration.
Pharmacomechanicalexperiments on human bronchi. Segments of bronchus were dis-
sected free from parenchymal lung tissue and preparations cut (3–4 mm length and 2–3 mm
internal diameter). Preparations were used immediately for experiments. Bronchial rings were
mounted in a 5 ml organ bath chamber (Pan-Lab,USA), containing Krebs-Henseleit solution
(37°C), gassed with 5% CO2 in O2 at 37°C (pH 7.4), under an initial load of 1–2 g, and the iso-
metric tension was recorded with a transducer (Grass FT03 isometric force transducer; Grass
Instruments, Quincy, MA, USA) connected to a PowerLab1 data acquisition system (AD
Instruments, Castle Hill, New SouthWales, Australia), as we reported previously [18]. Bron-
chial preparations were equilibrated for 60–90 min with changes in bath Krebs-Henseleit
solution every 20 min before any pharmacological intervention occurred. In all experiments,
the bronchi were pre-contracted with 1 μM carbachol. After the plateau was reached, increas-
ing concentrations of T2R agonists (chloroquine, denatonium, and saccharin) were then
added for constructing concentration-response curves. After the last concentration level of
T2R agonists, the maximum relaxation of each segment was evaluated by the addition of 0.1
mM papaverine.
Statistical analysis
Statistical analysis was performed using Prism 6 (GraphPad Software Inc, San Diego, CA,
USA). Data of MCC analysis are presented as mean±SD of % radiation counts at each time
point. Statistical analysis of results is carried out by analysis of variance (ANOVA) using one-
way ANOVA or two-way ANOVA followed by Bonferroni test. Significance is accepted when
P<0.05.
The concentration-response curves of T2R agonists increasing CBF and relaxing human
bronchi were constructed and analyzed by non-linear regression analysis and by Student’s t
test, as appropriate. The logEC50 values, defined as the concentration of drug which induces an
effect equal to 50% of its own maximal effect.
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Results
Measure of nasal mucociliary transport rate (NMTR) using micro-
CT-SPECT albumin macroagregates marked with Tc99m
Anesthetized guinea pig animals were undergoing drug ventilation during 10 min with differ-
ent T2Rs agonists chloroquine, denatonium or saccharine at 1 mM. After drug delivery, intra-
nasal MAA-Tc99m (100 μL; 10 mCi; particle diameter 5–90μm) particle suspension (one
droplet of 25 μL) was instilled on the beginning of nasal meatus and the distance traveled by
the radioisotope signal was monitored for 60 min throughout the nasal meatus cavity. Albumin
macroaggregates showed a constant velocity throughout the nasal meatus with a coefficient of
variability between animal measures of 7.64 ± 0.4%. The NMTR was 0.36± 0.04 mm/min in
vehicle ventilated animals (Fig 1A and 1B). The treatment with T2R agonists chloroquine,
denatonium and saccharin significantly increasedNMTR to 0.6±0.04 mm/min, 0.66±0.02
mm/min and 0.5±0.02 mm/min respectively (Fig 1C).
Effects of T2R agonists on nasal CBF
The basal nasal CBF of untreated cells was 9.96±0.20 Hz (n = 51). The non-selective T2R ago-
nists induced a concentration-dependent increase of CBF with a maximum increase of 30%
respect the baseline (Fig 2). The rank order of potency (EC50 values) was: diphenidol
(0.05 μM), denatonium (0.96 μM), chloroquine (1.52 μM), quinine (2.89 μM) and saccharin
(68.2 μM) (Fig 2). Diphenidol, denatonium, chloroquine and quinine at higher concentrations
(>1 mM) caused ciliary incoordination perturbingCBFmeasurements. Phenanthroline was
without effect.
Measure of bronchial mucociliary clearance using different micro-
CT-SPECT Tc99m marked radioisotopes
Three types of Tc99m marked substances were used to evaluate bronchial MCC. First; a solu-
tion containing 10 mCi (DTPA-Tc99m) (Molipharma, Valencia, Spain) was nebulized for 15
min on a rodent nebulizer. After DTPA-Tc99m delivery, the animals were removed from the
nebulizer chamber and allowed to breathe freely. Radioisotope signal was monitored through-
out the lung 252 dynamic images sections obtained with the micro-CT-SPECT. Radioisotope
signal showed a rapid decay because the rapid diffusion of aerosolizedDTPA between the alve-
olar/ capillary units through the ventilation perfusion process (Fig 3A–3C). None of the T2R
agonist increased bronchial MCCmeasures as acceleration of radioisotope signal decay (Fig
3D). SPECT images showed an irregular DTPA distribution without bronchial-tracheal expec-
toration throughout the measured time points, which correlates with the un-particulate nature
of DTPA solution which explain the lack of activity of T2R agonists. DTPA-Tc99m distribu-
tion reached extra-pulmonary locations reflecting the passage of the radioisotope from the
lung to the systemic circulation (Fig 3E) after 6h of ventilation.
The second analysis of bronchial MCC was performed using MAA-Tc99m. Intratracheal
instillation of MAA-Tc99m appeared patchy and centrally deposited at the earliest time point
which may reflect an elevated particle size and a lack of small bronchi distribution of albumin
macroaggregates (5–90μm; Fig 4). The radioisotope signal only decayed ~ 40% of the initial sig-
nal at the end of the 6h evaluation period (Fig 4). Furthermore, none of the T2R agonists
increased bronchial MCC suggesting incapacity of cilia to move albumin particle. The third
analysis was carried out with a suspension of Tc99m albumin nanocolloids (particle diameter
80nm) that was nebulized during 15 min. Inhalation of Tc99m albumin nanocolloids showed
a homogeneous distribution filling up the entire lung volume (Fig 5A). Physiological MCC was
Micro-CT-SPECT Mucociliary Function Analysis of Bitter Taste Agonists In Vivo
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monitored by combined micro-CT and SPECT images showing continuous clearance of
Tc99m albumin nanocolloids throughout the small bronchi to the tracheal section of lung
reflecting the bronchial MCC in the three dimension images of the animal lungs (Fig 5B and
5C). Non-treated animals showed a rapid loss of radioisotope signal during the first 2h of inha-
lation followed by slow decreased signal until 6h reaching the 49.9±2% of the initial signal (Fig
6). T2R agonists accelerated the albumin nanocolloid clearance showing 28.7±1.1%, 22.5
±0.24% and 38±7% of the initial signal for chloroquine, denatonium and saccharin respectively
at the end of 6h period (Fig 6).
Effects of T2R agonists on human bronchi relaxation
Chloroquine, denatonium and sacharin produced a concentration-dependent relaxation of the
carbachol-induced tone of human bronchi that achieve 90% to 100% of maximum relaxation
induced by papaverine. The rank order of potency as broncodilators (EC50 values) was, denato-
nium (50 μM), saccharin (180 μM) and chloroquine (220 μM) (Fig 7, Table 1).
The comparison of EC50 values relaxing human bronchi vs EC50 values increasing CBF for
chloroquine (220 μM vs 1.52 μM) and denatonium (50 μM vs 0.96 μM) showed that potency
was 100x and 50x higher stimulating ciliarymotility, respectively.
Discussion
The present work evaluates micro-CT coupled-SPECT three dimension technique to measure
MCC in guinea pig animals, on both, upper and lower airways which may be of potential value
as a preclinical model to evaluate compromised MCC in airway diseases as well as to evaluate
the effect of drugs on in vivoMCC. In this regard, we observed that T2R agonists increased
MCC in vivo by a combinedmechanism including the increase of CBF of epithelial ciliated
cells and bronchodilation.
Various methodologies have been used to evaluate in vivo lung deposition of different sub-
stances in small animals. Gamma scintigraphy [19], X-SPECT [20], positron emission
Fig 1. Nasal mucociliary transport rate (NMTR) measurement with combined micro-CT-SPECT macroaggregated albumin (MAA)-Technetium
99 metaestable (Tc99m) in guinea pig. A) MAA-Tc99m traveled distance at time 0. B) MAA-Tc99m traveled distance after 60 min of nasal
administration. C) Bitter taste receptor agonists chloroquine, denatonium and saccharin were aerosolized during 10 min before nasal MAA-Tc99m
administration and the distance traveled during 60 min was monitored. Nasal mucociliary transport rate was calculated as mm/min. Representative
images of n = 9 guinea pig per condition are showed. Colorimetric intensity scale adjusted for all images is shown. Results are expressed as mean ± SD.
One-way repeated measures analysis of variance (ANOVA): P<0.001. Post hoc Bonferroni test: *P<0.001 compared with controls.
doi:10.1371/journal.pone.0164399.g001
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tomography (PET) [21], magnetic resonance Image (MRI) [22] and fluorescence imaging [23]
can measure total lung deposition and oropharyngeal deposition of particles directly by using
radionuclides non-ionizable radiation and fluorescent dye. However, to our knowledge,micro-
CT coupled-SPECT technique has not been used to analyze nasal or MCC in preclinical small
animals. The advantage of this technique includes a better precision of data that includes differ-
ent nasal or lung section analysis (252 image slices) which produces 3D images compared to
the traditional 2D image producing technique, gamma scintigraphy or X-SPECT. 3D images
allowmore detailed data on regional lung deposition and can monitor the trachea-bronchial
release of particles or the velocity of nasal mucociliary transport since it is possible to visualize
the travelled length of particles. One of the best characterized radiotracer is the DTPA-Tc99m
solute that has been used to monitor ventilated lung regions to calculate ventilation/perfusion
ratio [24] in pulmonary embolisms, but also to study the alveolar wall integrity, nasal, tracheal
and bronchial absorption and permeability [25, 26]. However the utility of DTPA-Tc99m to
measureMCC is under debate. While, some authors have observed that mucociliary transport
mechanism does not contribute to radiotracer clearance [25], others use DTPA-Tc99m to
Fig 2. Concentration-response curves for bitter taste receptor (T2R) agonists on human nasal ciliary beat frequency CBF (Hz). CBF0
correspond to basal values of CBF when only vehicle was added to the culture medium. Non-selective agonists (chloroquine, denatonium, quinine,
saccharin and diphenidol) induced increases in CBF at the concentrations represented, with the exception of phenanthroline. The results are expressed
as a mean ± SD. Two-way repeated measures analysis of variance (ANOVA): P<0.001. Post hoc Bonferroni test: *P<0.05; **P<0.01; ***P<0.001 vs
CBF0.
doi:10.1371/journal.pone.0164399.g002
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measure it [27]. In the present work we observed a rapid pulmonary clearance of
DTPA-Tc99m that was mediated by broncho-alveolar absorption to systemic circulation rather
than MCC, since hepatic radiotracer signal capture was detected at 6h post-inhalation and no
movement of tracer was detected through the tracheo-bronchial apparatus. Furthermore, the
stimulation of T2R did not increase physiological DTPA-Tc99m clearance which indicates that
T2R activation does not affect pulmonary permeability and that DTPA-Tc99m radiotracer is
not cleared by MCC transport mechanism.
Next experiments were directed to evaluate nasal and bronchial MCC using a suspension of
MAA-Tc99m (particle diameter 5–90μm). Nasal administration of MAA-Tc99m showed a
Fig 3. Diethylene-triamine-pentaacetate (DTPA)-Tc99m evaluation as a radiotracer to monitor mucociliary
clearance. A) micro-computer tomography (CT) representative image to locate SPECT images. B) SPECT representative
image of nebulized DTPA-Tc99m at time 0. C) SPECT representative image of nebulized DTPA-Tc99m at time 360 min. D)
Effects of bitter taste agonists chloroquine, denatonium and saccharin on % DTPA-Tc99m radiation intensity. E)
Representative image of extra-pulmonary location of DTPA-Tc99m at time 360 min. Representative images of n = 12
guinea pig per experimental condition are showed. Colorimetric intensity scale adjusted for all images is shown. 100%
DTPA-Tc99m intensity corresponds to the start of experiments (t = 0min) for all experimental conditions). Results are
expressed as mean ± SD. One-way repeated measures analysis of variance (ANOVA): P>0.05. Post hoc Bonferroni test:
P>0.05 compared with controls.
doi:10.1371/journal.pone.0164399.g003
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constant movement through nasal meatus at 0.36 mm/min reflecting a useful tool to monitor
NMTR in vivo that has not been describedpreviously. NMTR shows a broad variability in the
literature ranging from 2.4 mm/min to 21.5 mm/min in humans [13] and 5.1 mm/min to 1.9
mm/min in rats [13]. Discrepancies observed in this work and the data reported in the litera-
ture can be explained by different techniques used, the animal species studied and also because
the published work is focused in tracheal and bronchial MCC velocities but not in nasal meatus
section.
In our study, the T2R agonist chloroquine and denatonium increasedNMTR. Saccharin
showed the lowest activity on NMTR probably because activates sweet receptors as well as
T2R, so could blunt some of the bitter effects of the compound [28]. The effect of T2R agonists
increasing NMTR is mediated by a direct mechanism on CBF. In fact, in isolated human nasal
ciliated cells T2R activation increased CBF. Furthermore, T2R agonists can activate solitary
chemosensory cells that reach the surface of the nasal epithelium and form synaptic contacts
with trigeminal afferent nerve fibers [29]. Solitary chemoreceptor cells express T2R and its
stimulation can induce the increase of inflammation of the nasal mucosa, the depression of
respiratory rate and the increase of MCC lowering mucus viscosity in response to T2R agonists
such as pseudomonas aeruginosa quorum [30–32].
In the airway, T2Rs are also expressed in bronchial smooth muscle cells of mouse [33, 34],
guinea-pig [35] and human isolated airway preparations [11, 36–39] where they mediates
bronchodilation. In human nose mucosa [40] have been described at least 22 types of T2Rs
[41]. It has been described that these compounds augment CBF in human bronquial epithelial
cells [10], but the effect on human sinonasal epithelial cells is unclear.
Fig 4. Macroaggreggate albumin (MAA)-Tc99m evaluation as a radiotracer to monitor mucociliary clearance. A) Micro-CT coupled to SPECT
representative image of intratracheal instillated MAA-Tc99m at time 0. B) Micro-CT coupled to SPECT representative image of intratracheal instillated
MAA-Tc99m at time 360 min. C) Effects of bitter taste agonists chloroquine, denatonium and saccharin on % MAA-Tc99m radiation intensity.
Representative images of n = 12 guinea pig per condition are showed. Colorimetric intensity scale adjusted for all images is shown. 100% MAA-Tc99m
intensity corresponds to the start of experiments (t = 0min) for all experimental conditions). Results are expressed as mean ± SD. One-way repeated
measures analysis of variance (ANOVA): P>0.05. Post hoc Bonferroni test: P>0.05 compared with controls.
doi:10.1371/journal.pone.0164399.g004
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The T2Rs vary in their selectivity towards bitter taste compounds. Braun et al. [40]
described, the following rank order expression of T2R subtypes in the human nasal respiratory
mucosa: T2R5> 4> 3> 31> 10> 14> 13> 46> 43>39> 7. In our study, we used non-
selective T2R agonists to cover the widest range of T2R with higher expression in the human
nose [40]. Most of the agonists used in the present study activated T2R3, 4, 7, 10, 13, 14, 31, 39,
43, 46 and 47. Previous observations showed that the T2R agonist denatonium stimulated cal-
cium-dependent CBF in human bronchial ciliated cells [10]. However, Lee et al. [42] reported
that application of 10 mM denatonium benzoate slowed CBF in sinonasal cells suggesting that
sinonasal ciliated epithelial cells do not express functional denatonium responsive T2Rs. In
this work, T2R concentration higher than 1mM caused an uncoordinated CBF which was
Fig 5. Tc99m albumin nanocolloids evaluation as a radiotracer to monitor mucociliary clearance. A) Representative micro-CT-
coupled SPECT two dimension sections at time 0, 2h and 4h after aerosolized Tc99m albumin nanocolloids. B) Representative micro-CT-
coupled SPECT three dimension images at time 0, 2h and 4h after aerosolized Tc99m albumin nanocolloids. C) Representative SPECT
three dimension images at time 0, 2h and 4h after aerosolized Tc99m albumin nanocolloids. Colorimetric Colorimetric intensity scale
adjusted for all images is shown. Representative images of n = 12 guinea pig are showed.
doi:10.1371/journal.pone.0164399.g005
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translated in a decrease of CBF, as observedby high speed video-microscopy, which may
explain previous observations on decreasedCBF as an over-activation of T2R.
In this study, the most potent T2R agonist increasing CBF was diphenidol (agonist of T2R4,
10, 14, 31, 39, and 40), followed by denatonium (T2R4, 10, and 39), chloroquine (T2R3, 10 and
Fig 6. Bitter taste receptor agonists increase Tc99m albumin nanocolloid bronchial mucociliary clearance in guinea pig. A) Micro-CT coupled to
SPECT representative image of aerosolized Tc99m albumin nanocolloids at time 0 and 360 min in presence or absence of chloroquine, denatonium and
saccharin. B) Effects of bitter taste agonists chloroquine, denatonium and saccharin on % Tc99m albumin nanocolloids radiation intensity.
Representative images of n = 12 guinea pig per condition are showed. Colorimetric intensity scale adjusted for all images is shown. 100% Tc99m
albumin nanocolloids intensity corresponds to the start of experiments (t = 0min) for all experimental conditions). Results are expressed as mean ± SD.
One-way repeated measures analysis of variance (ANOVA): P<0.01. Post hoc Bonferroni test: *P<0.05 compared with controls.
doi:10.1371/journal.pone.0164399.g006
Fig 7. Concentration-response curves for bitter taste receptor agonists (chloroquine, denatonium
and saccharin) on human bronchi. The results are expressed as a percentage of the relaxation observed
with 0.1 mM papaverine (mean ± SD) of n = 4 human bronchi per condition.
doi:10.1371/journal.pone.0164399.g007
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39), quinine (T2R4, 10, 14, 31, 39, and 40) and saccharin (T2R31, 43, and 44). However, phe-
nanthroline (selective agonist of T2R5) did not modifiedCBF which implicate multiple T2R
subtypes, but not all, in this effect.
In contrast to nasal MCC, the use of MAA-Tc99m to measure bronchial MCC was not
effective. Intratracheal instillation administered via the endotracheal route is a non-invasive
aerosol pulmonary delivery technique which allows depositing particle suspensions in low air-
ways avoiding traditional invasive surgical intratracheal administration [15]. In this work,
intratracheal instillation of MAA-Tc99m appeared patchy and centrally deposited with a slow
clearance that was not modifiedwith the T2R administration, remaining ~75% of retention of
MAA-Tc99m in the lung of guinea pig after 6h of instillation. As show Fig 4B, MAA-Tc99m
showed a good tracheal clearance but not in bronchial tree. This phenomenon could be
explained by the anatomy of guinea pig tracheo-bronchial tree which is 2100 ± 500 μm in tra-
cheal diameter allowing a good tracheal transport. However, bronchi, bronchioles or alveolar
ducts smaller diameter (100–150 μm) could retain MAA-Tc99m particles being trapped possi-
bly by binding to the bronchial tissue.
Previous lung MCC experiments have determined that most of the particles deposited in
the rat bronchial tree are cleared after about 6 to 8 h of inhalation [13]. However, other data
demonstrated that intratracheal instillation particle remained with a high percentage of reten-
tion in rats when compared with nose-only aerosol inhalation [19] which may be explained by
the method used for particle delivery or by the elevated particle size. In fact, the elevated parti-
cle size of the MAA-Tc99m particles, together with the incapacity of T2R to clear radiotracer,
indicates the incapacity of bronchial ciliated cells to clear elevated particle size. These results
are apparently contrary to that observed in nasal meatus which may be explained by the ana-
tomical differences between the nasal cavity and bronchial tree.
In this regard, other particles suspensions joined to Tc99m have been employed to analyze
MCC. Thus for example, Tc99m labeled sulfur colloid (Tc99m-SC; particle size< 100nm [43])
has been used thoroughly to evaluate MCC by means of gamma scintigraphy imaging proce-
dure [19]. Similar results have been obtained with Tc99m albumin nanocolloids (particle diam-
eter80nm) in humans [44]. In the present work, MCC was characterized by a rapid first
trachea-bronchial MCC followed by a more sustained and slow clearance of small bronchial
particles [13]. Mechanism involved in lung particle clearance was attributed mostly to the
MCCmechanism rather to the increase on pulmonary permeability since radiotracer particles
were observed ascending from the bronchi to the trachea in a time-dependentmanner. How-
ever we cannot exclude some Tc99m albumin nanocolloid pulmonary absorption to the sys-
temic circulation. It is interesting to note that T2R agonist increased bronchial MCC at
concentration that were also responsible to the increase of CBF and bronchodilation. Dual
mechanism involving combination of bronchodilation and ciliarymovement has been
describedpreviously for T2R agonists and could synergized increasingMCC. In chronic airway
diseases such as asthma or chronic obstructive pulmonary disease (COPD), increased viscosity
and mucus overproduction can end up forming mucus plugs whereby infection or localized
atelectasis can be observed.Narrowing of airways combined with rubberymucus can form
Table 1. Maximum relaxation (Emax) and potency (log EC50)observed with non-selective T2R ago-
nists on human bronchi.
Emax (%) log EC50 n
Chloroquine 91.0±2.8 -3.662±0.05 8
Denatonium 96.8±1.6 -4.310±0.13 7
Saccharin 98.3±1.7 -3.741±0.44 9
doi:10.1371/journal.pone.0164399.t001
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mucus plugs obstructingmucociliary clearance. In this context, bronchodilation can increase
the airway diameter, and with the aid of transient increases in expiratory air flow favours that
mucus trapped can be released [45].
T2R agonists have been shown to induce relaxation of airway smooth muscle in animal [11,
33, 35, 39] and human [11, 33, 36, 37] at concentrations in the range observed in this work.
One limitation of these compounds as bronchodilators is their low potency [37], what limits its
clinical use. The results for chloroquine, denatonium and saccharin are consistent with other
studies in human bronchi, showing bronchodilation with EC50 values in the mM range [36]. In
contrast, these compounds were more potent increasing CBF, so the potency stimulating CBF
for chloroquine and denatonium was 100x and 50x higher respectively. This implies that clini-
cal effect on CBF could be achieved at lowest doses than bronchodilation. It could be difficult
to understand, why EC50 of bitter compounds for bronchodilation and CBF differ so much?. In
this regard, T2R activation increases CBF through the increase of intracellular calcium in the
cilia. However T2R activation induces bronchodilation through other mechanisms such as
reduction in calcium oscillation by activation of calcium-activated potassium channels (BKCa)
[11]. Also CBF system implicates a rapid diffusion of drugs to be directly in contact with cilia,
unlike human ring bronchi that needs diffusion through the bronchial epithelium and base-
ment membrane to be in contact with bronchial smoothmuscle.
In summary, nasal administration of MAA-Tc99m particles monitored through the micro-
CT coupled-SPECT is a useful technique to analyze in vivoNMTR, while Tc99m albumin
nanocolloids are preferred to the study of low airwaysMCC. The use of T2R agonists in this in
vivomodel corroborated previous ex-vivo/ in vitro findings showing an increase of NMTR and
bronchial MCC.
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